{"id":2125,"date":"2026-05-07T17:48:19","date_gmt":"2026-05-07T15:48:19","guid":{"rendered":"https:\/\/sites.unica.it\/pe2026\/?p=2125"},"modified":"2026-05-08T18:17:29","modified_gmt":"2026-05-08T16:17:29","slug":"lisa-sequeira","status":"publish","type":"post","link":"https:\/\/sites.unica.it\/pe2026\/2026\/05\/07\/lisa-sequeira\/","title":{"rendered":"Lisa Sequeira"},"content":{"rendered":"\n<hr class=\"wp-block-separator has-alpha-channel-opacity\" \/>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile\" style=\"grid-template-columns:16% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"512\" height=\"512\" src=\"http:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px.png\" alt=\"\" class=\"wp-image-312 size-full\" srcset=\"https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px.png 512w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-300x300.png 300w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-150x150.png 150w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-270x270.png 270w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-192x192.png 192w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-180x180.png 180w, https:\/\/sites.unica.it\/pe2026\/files\/2025\/09\/cropped-00_Profile_Tondo-Social__Spilla_PE26_1200px-32x32.png 32w\" sizes=\"auto, (max-width: 512px) 100vw, 512px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-text-align-left\"><strong>PC35 &#8211; Lisa Sequeira<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-left\">RISE-Health, Faculty of Medicine, University of Porto, Portugal<\/p>\n\n\n\n<p class=\"has-text-align-left\"><strong>lsequeira@med.up.pt<\/strong><\/p>\n<\/div><\/div>\n\n\n\n<figure class=\"wp-block-table\"><div class=\"table-responsive\"><table class=\"table  table-striped table-bordered table-hover\"  class=\"has-fixed-layout\"><tbody><tr><td><strong><strong>Polymerization-induced self-assembly of ROS-sensitive nanovesicles for dual-drug delivery in ALS therapy<\/strong><\/strong><\/td><\/tr><tr><td><em>Sequeira Lisa<sup>1<\/sup>, SaraivaRita<sup>1<\/sup>, Alfenim Ana Rita<sup>1<\/sup>, Moreira Joana<sup>1<\/sup>, Eberhardt J.<sup>2<\/sup>, Pinto Miguel<sup>1<\/sup>, Brendel Johannes<sup>2<\/sup>, Fernandes Carlos<sup>1<\/sup><\/em><br><br><em><sup>1<\/sup><\/em> RISE-Health, Faculty of Medicine, University of Porto, Alameda Prof. Hern\u00e2ni Monteiro, 4200-319, Porto, Portugal<br><em><sup>2<\/sup><\/em> Macromolecular Chemistry, University of Bayreuth, Universit\u00e4tsstr. 30, 95447 Bayreuth, Germany<\/td><\/tr><tr><td><strong>Abstract<\/strong><br>Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disorder with a multifactorial pathophysiology characterized by an oxidative environment. Current therapies primarily focus on extending survival and slowing the progression of physical decline<sup>1<\/sup>, underscoring the urgent need for neuroprotective strategies that target multiple mechanisms simultaneously. Nanotechnology-based delivery systems offer a promising approach to enhance therapeutic efficacy compared to conventional drug administration that when combined with reactive oxygen species (ROS)-sensitive moieties enable the controlled and targeted release of therapeutic agents. The combination of Riluzole (RIL), an FDA-approved drug for ALS, with Rasagiline Mesylate (RAS), which provides neuroprotective effects, represents a strategy to achieve synergistic benefits and improve treatment outcomes. To realize this potential, ROS-sensitive RIL\/RAS-loaded vesicles were synthesized via polymerization-induced self-assembly (PISA). Poly(N-acryloylmorpholine) (PNAM) served as the macro chain transfer agent, while N-acryloylthiomorpholine (NAT) was used as the monomer<sup>2<\/sup>. Different PNAM\/NAT ratios were tested as well as the concentration of NAT in the reactional mixture. The drug content in the vesicles was quantified using a high-performance liquid chromatography (HPLC) system, while the size and morphology of the vesicles were characterized through dynamic and electrophoretic light scattering (DLS and ELS). The study of the degradation kinetics was performed under physiological and oxidative environment conditions at 37 \u00baC. A preliminary evaluation of the pharmacological effect of the novel ROS-sensitive nanoformulations was performed using neuronal and nasal epithelial cell lines.<\/td><\/tr><tr><td><strong>References &nbsp;<\/strong><br>[1] Mead, R. J.; Shan, N.; Reiser, H. J.; Marshall, F.; Shaw, P. J. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation.&nbsp;<em>Nature Reviews Drug Discovery<\/em>&nbsp;<strong>2022<\/strong>,&nbsp;<em>22<\/em>&nbsp;(3), 185\u2013212.&nbsp;DOI: 10.1038\/s41573-022-00612-2<br>[2] Sobotta, F. H.; Kuchenbrod, M. T.; Grune, C.; Fischer, D.; Hoeppener, S.; Brendel, J. C. Elucidating preparation-structure relationships for the morphology evolution during the RAFT dispersion polymerization of N-acryloyl thiomorpholine.&nbsp;<em>Polymer Chemistry<\/em>&nbsp;<strong>2021<\/strong>,&nbsp;<em>12<\/em>&nbsp;(11), 1668\u20131680.&nbsp;DOI:10.1039\/d0py01697g.<br><br>This work was funded by FEDER funds through national funds by FCT \u2013 Foundation for Science and Technology under research grants 2023.13291.PEX, 2024.16701.PEX and under the project RISE-Health \u2013 UID\/06397\/2025. This work was also supported by the project IMPULSE (Funding programme: Horizon Europe; Grant agreement number: 101132028). This work was also supported by FCT project reference 2021. 04016.CEECIND\/CP1655\/CT000(DOI: 10.54499\/2021.04016.CEECIND\/CP1655\/CT0004). M.P. (101132028), J.M. (2023.13291.PEX\/201569) and A.R.A. (2023.01250.BD) grants are also supported by FCT. C.F. thanks the FCT for the financial support of his work contract through the Scientific Employment Stimulus\u2014Individual Call (2021. 04016.CEECIND\/CP1655\/CT0004).<\/td><\/tr><\/tbody><\/table><\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>PC35 &#8211; Lisa Sequeira RISE-Health, Faculty of Medicine, University of Porto, Portugal lsequeira@med.up.pt Polymerization-induced self-assembly of ROS-sensitive nanovesicles for dual-drug delivery in ALS therapy Sequeira Lisa1, SaraivaRita1, Alfenim Ana Rita1, Moreira Joana1, Eberhardt J.2, Pinto Miguel1, [&hellip;]<\/p>\n","protected":false},"author":10371,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2125","post","type-post","status-publish","format-standard","hentry","category-senza-categoria"],"_links":{"self":[{"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/posts\/2125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/users\/10371"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/comments?post=2125"}],"version-history":[{"count":3,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/posts\/2125\/revisions"}],"predecessor-version":[{"id":2370,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/posts\/2125\/revisions\/2370"}],"wp:attachment":[{"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/media?parent=2125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/categories?post=2125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.unica.it\/pe2026\/wp-json\/wp\/v2\/tags?post=2125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}